NASDAQ: VANI
Vivani Medical Inc Stock Forecast, Predictions & Price Target

Analyst price target for VANI

Based on 1 analyst offering 12 month price targets for Vivani Medical Inc

Min Forecast
$4.00+247.83%
Avg Forecast
$4.00+247.83%
Max Forecast
$4.00+247.83%

Should I buy or sell VANI stock?

Based on 1 analyst offering ratings for Vivani Medical Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VANI stock forecasts and price targets.

VANI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-19

1 of 1

Forecast return on equity

Is VANI forecast to generate an efficient return?

Company
-168.19%
Industry
29.26%
Market
56.76%
VANI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VANI forecast to generate an efficient return on assets?

Company
-55.15%
Industry
10.9%
VANI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VANI earnings per share forecast

What is VANI's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.38
Avg 2 year Forecast
-$0.33

VANI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VANI$1.15$4.00+247.83%Buy
IMRX$1.90$14.33+654.37%Strong Buy
SNTI$2.60$8.50+226.92%Strong Buy
ARMP$1.87$9.00+381.28%Buy
STRO$0.80$1.70+112.77%Hold

Vivani Medical Stock Forecast FAQ

Is Vivani Medical Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: VANI) stock is to Buy VANI stock.

Out of 1 analyst, 0 (0%) are recommending VANI as a Strong Buy, 1 (100%) are recommending VANI as a Buy, 0 (0%) are recommending VANI as a Hold, 0 (0%) are recommending VANI as a Sell, and 0 (0%) are recommending VANI as a Strong Sell.

If you're new to stock investing, here's how to buy Vivani Medical stock.

What is VANI's earnings growth forecast for 2025-2026?

(NASDAQ: VANI) Vivani Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 22.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.

Vivani Medical's earnings in 2025 is -$23,749,000.On average, 1 Wall Street analyst forecast VANI's earnings for 2025 to be -$22,512,683, with the lowest VANI earnings forecast at -$22,512,683, and the highest VANI earnings forecast at -$22,512,683.

In 2026, VANI is forecast to generate -$19,550,488 in earnings, with the lowest earnings forecast at -$19,550,488 and the highest earnings forecast at -$19,550,488.

What is VANI's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: VANI) forecast ROE is -168.19%, which is considered weak.

What is VANI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year VANI price target, the average VANI price target is $4.00, with the highest VANI stock price forecast at $4.00 and the lowest VANI stock price forecast at $4.00.

The Wall Street analyst predicted that Vivani Medical's share price could reach $4.00 by May 19, 2026. The average Vivani Medical stock price prediction forecasts a potential upside of 247.83% from the current VANI share price of $1.15.

What is VANI's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: VANI) Vivani Medical's current Earnings Per Share (EPS) is -$0.43. On average, analysts forecast that VANI's EPS will be -$0.38 for 2025, with the lowest EPS forecast at -$0.38, and the highest EPS forecast at -$0.38. In 2026, VANI's EPS is forecast to hit -$0.33 (min: -$0.33, max: -$0.33).

What is VANI's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: VANI) forecast ROA is -55.15%, which is lower than the forecast US Biotechnology industry average of 10.9%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.